Our not-quite-post-pandemic summer is coming to an end. Time to pack away the bathing suit and get serious again—with these curated curiosities combed from the now-barren Drug Channels beach:
- OptumRx joins the PBM GPO game
- Pharmacy DIR fees hit $11 billion
- A terrific resource on state biosimilar laws
- Patient views on utilization management
Plus, my social media success…from a (print) newspaper ad!
P.S. Please join the more than 12,100 consumers of my daily commentary and links to neat stuff at @DrugChannels on Twitter. You can also find me on LinkedIn, where I have more than 19,500 followers. Recent topics have included: Express Scripts’ 2022 formulary exclusion list, Amazon’s pharmacy, generics in Part D, 340B research, zero-dollar copay, pass-through rebates, PBMs’ spread pricing, Rite Aid’s Bartell deal, healthcare pricing trends, the DSCSA, John Venn, and more.
Read more »
Source: Post feed
